# Charming Medical Limited share price (Charming Medical Limited, MCTA)

> Charming Medical Limited's share price, valuation and earnings point in different directions. The next one or two quarters should make it clearer. MCTA · Healthcare · Medical Care Facilities · data as of 11 November 2025. Page: https://www.sectoralpha.in/us/stocks/mcta

Sector Alpha also publishes a daily newsletter that explains one Indian stock at a time: https://newsletter.sectoralpha.in/?utm_source=sectoralpha&utm_medium=ai_text&utm_campaign=llms

## Key numbers

- Price: $29.36
- P/E: 767.2×, against its own history
- Revenue (Mar 2026): $2.6 M (−18.8% on a year ago)
- Profit (Mar 2026): $50.0 K (−93.2% on a year ago)
- Operating margin: 4.9% (−24.0 points on a year ago)
- ROE: 0%, FY26

Biggest thing to watch: the price is not yet in a clear uptrend, so timing is the risk more than the business. ## What is the Charming Medical Limited share price? Charming Medical Limited's share price was $29.36 at the close on 11 November 2025. Since its first close in our records, on 24 October 2025, it has traded between $7 and $29, and at that close it was at the high of that range. There is not enough history yet to compare it with the S&P 500. Charming Medical Limited is a new listing: we have 1 month of share prices so far, since 24 October 2025. The price chart, its averages and its phases need more history, so they appear once there is enough. This page treats a rise as over when the price closes below its 200-day average on two Fridays in a row. ## What dividend does Charming Medical Limited pay? Charming Medical Limited pays no dividend. In the last 6 reported quarters it declared no dividend per share, so there is no payout history to chart and no yield to show. Companies like this usually keep their earnings in the business, so the cash-flow sections show where that cash goes. ## Which stock lists is Charming Medical Limited on? Charming Medical Limited is not in the Nasdaq 100, the S&P 500 or the Dow Jones 30, and is not on the US tech stocks list. ## Is Charming Medical Limited profitable? Charming Medical Limited earned $50.0 K of net profit in the Mar 2026 quarter, −93.2% on the same quarter a year earlier. The full FY26 year was a loss of $23.0 K. That is 1.9% of the quarter's revenue. The same quarter a year earlier earned $403 K. For the full year, FY26 profit was −$23.0 K (−101.9% on the year before). Why profit moved: revenue changed −18.8% on a year earlier and the margin moved −24.0 percentage points. Sales did the work while the margin got thinner. On average over the last four quarters, profit changed −25.6% and revenue −9.3%. Profit is growing slower than sales: rising costs are taking part of the growth. ## How much revenue does Charming Medical Limited make, and is it growing? Charming Medical Limited reported $2.6 M of revenue in the Mar 2026 quarter, −18.8% on the same quarter a year earlier. Over 3 years it has grown 10.8% a year on average. The last full year, FY26, came in at $4.8 M. FY26 revenue was $4.8 M, −22.7% on the year before. Recent pace: the last four quarters grew −9.3% on average, against 10.8% a year over the longer run, so this year is growing slower than its own long-run rate. ## How much of every $100 of sales does Charming Medical Limited keep? Charming Medical Limited's operating margin was 4.9% in the Mar 2026 quarter, 24.0 percentage points lower than the same quarter a year ago. Over the last four quarters it has moved −14.2 percentage points. Across 4 years it has been between −10.7% and 25.7%. The latest quarter is within that range. Why the margin moved: operating margin changed −14.2 percentage points on the year while gross margin changed +0.4 points. So the drop came mostly from costs below the gross margin, such as staff and overheads, measured against sales. ## Is Charming Medical Limited's profit turning into cash? Over the last 2 years, 36% of Charming Medical Limited's reported profit came in as cash from its operations, a gap worth watching. In FY26 its operations used $1.2 M of cash, against −$23.0 K of profit. After $340 K of spending on assets, free cash was −$1.6 M: it spent more than its operations brought in. Cash-flow figures here are yearly, because quarterly cash statements are not published, so this section changes once a year. Why: the cash figure is clear, but the day counts behind it are not in our data, so we show it without guessing the reason. What to look at next: the main use of cash is spending on assets. The next section checks what that spending is building. ## Where does Charming Medical Limited's cash go? Charming Medical Limited does not report the customer, stock and supplier day counts a cash cycle needs, so this section looks at its spending on assets instead. It spent $839 K on assets over the last 3 years. Averaged over those years that is 5.8% of FY26 revenue a year. Nothing is estimated in place of the missing day counts, so no cash-cycle chart is drawn. Spending on assets: $839 K over the last 3 years. In short: the cash is going into new capacity, not getting stuck in the daily cycle. The question is whether the new capacity earns. ## What is Charming Medical Limited's P/E ratio, and how does it compare with its own history? Charming Medical Limited's P/E is 767.2×, with too little history to compare. This compares the share price with the company’s own past. It does not say what the business is worth. In short: there is too little history to say whether the multiple is high or low for this company, so the earnings trend underneath matters more than the multiple. ## Is the Charming Medical Limited business getting better or worse? Charming Medical Limited's business trend cannot be read yet. There are fewer than eight usable quarters of growth figures, so there is not enough history to read the trend. This is based on 4 quarters of 1 measure, with some gaps. Why it matters: with too little history, we say so rather than guess a direction. One or more growth lines have an extreme jump caused by comparing with a near-zero or loss-making quarter. Those jumps are capped before reading and drawn at the edge of the chart, so one odd quarter does not decide the result. There are fewer than eight usable quarters, so this page does not guess a direction from so little history. ## How much does Charming Medical Limited earn on its capital? Charming Medical Limited earned a ROE of 0% in FY26. That is up from a low of −68% in FY24. Its return on capital used (ROIC) is left out: on sales this small it reads 22%, a number that says nothing useful about the business. It comes from a −0.5% net margin and 0.49× asset turnover (sales divided by assets). Why the return is what it is (FY26): a −0.5% net margin × 0.49× asset turnover × 1.90× leverage (assets divided by equity) ≈ −0.5% on equity. The margin does its share; borrowing is a big part of it. ## Does Charming Medical Limited have too much debt? Charming Medical Limited has total debt of $908 K against shareholder equity of $5.2 M as of Mar 2026, so its debt is 0.18× its equity, which is very little. Year by year, that ratio went from −1.43 in FY23 to 0.18 in FY26. So the returns on this page come from the business, not from borrowed money. ## What is the Charming Medical Limited shareholding pattern? We have no ownership or short-position figures for Charming Medical Limited, so this section says so rather than fill the gap. At normal trading volumes, closing those positions would take about 2.0 days. US companies do not publish a quarter-by-quarter list of owners, so this page uses short interest instead. ## How far is Charming Medical Limited from balance-sheet trouble? For Charming Medical Limited, the Z-score is 40.59. A Z-score above about 3 is safe and below about 1.8 signals danger, so this is well clear of danger. It estimates how far the balance sheet is from trouble; it is not a forecast of failure. Why it matters: a Z-score of 40.59 is well clear of the danger zone, so the balance sheet is not the risk here. ## How does Charming Medical Limited rank in its industry? There is no score against its industry: Charming Medical Limited is not among the largest members shown in this industry comparison for Medical Care Facilities. The score ranks a company within its industry: each measure is scored against the other members. Without that group there is no score, so none is shown. ## Which companies is Charming Medical Limited compared with? No sector comparison is shown here, not among the largest members shown in this industry comparison. ## Which companies are close to Charming Medical Limited in size? Charming Medical Limited is the 34th largest of 38 Medical Care Facilities companies on Sector Alpha by market value (scores of 3 November 2026). Just above it: InnovAge Holding Corp., GMR Solutions Inc. and The Oncology Institute, Inc. Just below it: Cross Country Healthcare, Inc., Strata Critical Medical, Inc. and Auna S.A. ### Medical Care Facilities companies close in size

1. [InnovAge Holding Corp.](https://www.sectoralpha.in/us/stocks/innv) $1.2 billion
2. [GMR Solutions Inc.](https://www.sectoralpha.in/us/stocks/gmrs) $885 million
3. [The Oncology Institute, Inc.](https://www.sectoralpha.in/us/stocks/toi) $646 million
4. Charming Medical Limited $504 million
5. [Cross Country Healthcare, Inc.](https://www.sectoralpha.in/us/stocks/ccrn) $428 million
6. [Strata Critical Medical, Inc.](https://www.sectoralpha.in/us/stocks/srta) $393 million
7. [Auna S.A.](https://www.sectoralpha.in/us/stocks/auna) $334 million

[All 38 Medical Care Facilities companies, largest first](https://www.sectoralpha.in/us/sectors/medical-care-facilities#all-companies)

### Companies close in size in other industries

1. [Galiano Gold Inc.](https://www.sectoralpha.in/us/stocks/gau) $506 million · Gold
2. [NRC Health](https://www.sectoralpha.in/us/stocks/nrc) $506 million · Health Information Services
3. Charming Medical Limited $504 million
4. [AngioDynamics, Inc.](https://www.sectoralpha.in/us/stocks/ango) $504 million · Medical Instruments & Supplies
5. [Algoma Steel Group Inc.](https://www.sectoralpha.in/us/stocks/astl) $504 million · Steel

## What else do people ask about Charming Medical Limited? ### What is Charming Medical Limited Limited's stock price today? Charming Medical Limited's stock price is $29.36. The whole company is worth $504 M on the market. It is at its highest price of the past 52 weeks (range $7 to $29) (as of 11 November 2025). ### What were Charming Medical Limited Limited's latest quarterly results? Charming Medical Limited reported revenue of $2.6 M and net profit of $50.0 K for the Mar 2026 quarter. Revenue fell 18.8% and profit fell 93.2% compared with a year earlier. Earnings per share were $0.00. The operating margin was 4.9%, 24.0 percentage points lower than a year earlier (as of 11 November 2025). ### What is Charming Medical Limited Limited's market cap? Charming Medical Limited's market capitalisation is $504 M at a stock price of $29.36. Market cap is the share price times the number of shares, so it changes whenever the price moves (as of 11 November 2025). ### How is Charming Medical Limited Limited performing? Charming Medical Limited's latest readings are below. In its latest quarter, revenue fell 18.8% and profit fell 93.2% compared with a year earlier. This describes what the data did, not a rating (as of 11 November 2025). ### Will Charming Medical Limited Limited's stock price go up? This page does not forecast Charming Medical Limited's stock price. What it shows instead: the stock price is $29.36. Nobody can reliably say which way a price will move, and this site does not try (as of 11 November 2025). ### Where is Charming Medical Limited Limited in its business cycle? Charming Medical Limited's FY26 operating margin was 2.3%, against a 4-year range of −10.7% to 25.7%: the middle of its own range, neither a peak nor a low. The latest quarter was 4.9%. Comparing margins with a company's own long history is a good way to see where it is in its cycle (as of 11 November 2025). ### What could break the Charming Medical Limited Limited story? Biggest thing to watch: the price is not yet in a clear uptrend, so timing is the risk more than the business. On price, this page treats a rise as over when the share price closes below its 200-day average on two Fridays in a row (as of 11 November 2025). ### Is Charming Medical Limited Limited a stock worth studying right now? What the numbers show: Charming Medical Limited's share price, valuation and earnings point in different directions. The next one or two quarters should make it clearer. The main open question: the next one or two quarters of results. Every number on this page is worked out by code from the published figures, with no forecasts and no price opinions (as of 11 November 2025). This is research, not advice. We’re not SEBI-registered.